Octreotide and the mTOR inhibitor RAD001 (everolimus) block proliferation and interact with the Akt-mTOR-p70S6K pathway in a neuro-endocrine tumour cell Line. by Grozinsky-Glasberg, S, Franchi, G, Teng, M, Leontiou, C, Ribeiro de Oliveira, A, Dalino, P, Salahuddin, N, Korbonits, M, Grossman, AB